plus reduce misery by early detection."
(A World Wide Humanitarian Medical Project)
In a time when higher medical quality demands are needed for a lower cost to the patients
and better improved tools for the Medical Doctors and Physicians; is demanded by
the Medical field.
The Population is growing faster and the number of Medical Students in school are less per
Wall Street and other resources, the demand is greater then ever.
That is why this advanced medical project, is needed and will meet and/or exceed the
quality tool that Medical Doctors and Physicians require and at a lower costs to patients.
The need for cheaper medical tools that reduce the ever growing Healthcare Explosion;
Demands.
Company Name: Is a new startup, (World Wide Retinal Imaging) DBA in Williamson County,
TX USA
(USA - Central Time Zone - If calling, Please call during my day time hours)
The main activities will be:
First, Develop Imaging Software For The Twenty-Nine (29) Diseases
Second, Marketing In USA, Then Worldwide
Third, Establish Medical Lab Service Facilities In Major Cities Around The World.
Duane F. Harvey; the Sole Owner (100%) - Texas 78641 USA (512) 260-0001
Duane F. Harvey; Secretary & Board Member, acting - Chairman of the Board, CEO, and President
Project Name: World Wide Retinal Imaging - Technologies, to help improve and extend better health by early detection and to reduce future long term suffering.
By developing imaging software for the known and valid 29 disease patterns and using a Retinal Camera, the Medical Doctor can see more indepht into the eyes of their patients.
The doctor now uses a hand held ophthalmoscope in their office or hospitals, which is like a childs magnifier vs an electron microscope.
The doctors evaluate the health status of their patients by the patterns they see in the retina of the eyes.
Called pattern recognition.
This tye of method of examination is very judgmental and subject to many errors and wrong judgements.
With the retinal camera and our software scanning system utilizing data comparison, we will be able to detect minute changes by early detection.
Permanent records will be produced for evaluation and future comparisions, by weeks, months, and years.
Further comparisons over time with previous data, or history data compared to current data, are made to detect changes within the individual health status of a patient.
The Hand Held Ophthalmoscope that the Medical Doctors uses, and they cannot see the very small indications which they miss.
(Need to do Research for Cancer, too)
| 01. Neoplastic Disease | 16. Liver Dysfunction |
| 02. Neoplastic Disease 1 | 17. Arthritis, Joints |
| 03. Hypoglycemia | 18. Atherosclerosis |
| 04. Anemia | 19. Arthritis |
| 05. Macroglobulinemia | 20. Rheumatoid Arthritis |
| 06. Diabetes | 21. Gout |
| 07. Diabetes, Chemical | 22. Hemorrhoids |
| 08. Diabetes, Juvenile | 23. Dystrophy |
| 09. Diabetes, Mellitus | 24. Neoplastic Disease 2 |
| 10. Diabetes, Brittle | 25. Hodgkin's Disease |
| 11. Pancreatic Myxedema | 26. Gall Bladder Disease |
| 12. Septicemia | 27. Osteomyelitis |
| 13. Hepatic Cirrhosis | 28. Hepatitis |
| 14. Renal Dysfunction | 29. Hypertension |
| 15. Liver Cirrhosis |
I want to get the retinal camera that an Ophthalmologist uses and lease it to the general Medical Doctors to use on their patients to take pictures of the retina and send us the digital data from the camera.
The ophthalmologists look at eye diseases and eye injuries, only.
Not diseases in the whole human body.
The ophthalmologists have a very powerful tool called the Retinal Camera, not fully being utilized in the Medical field.
We are not in competition with Ophthalmologists.
When our system detects any eye injuries or disease, we will flag the Medical Doctors to refer the patient to an Ophthalmologist.
We will scan the retinal pictures and create a permanent record of the patient's health status.
This process is non-invasive, non-harmful procedure, and is comprehensive.
This process will assists in early detection of many forms of diseases.
Scanning results from the retinal pictures will provide a measure of intensity or level of severity.
The company's plans are to set up centralized lab facilities across the United States.
This is based on where there is a sufficient market demands.
Parallel to this is to branch out to other countries.
As the market grows, we will be setting up new labs facilities around the world.
All patients will be under the care of their Medical Doctors and not of the company.
The Medical Doctors will use our data and they will be totally responsibly for all interpretation of the data and all follow-ups to validate all findings.
If data appears unusual, the Medical Doctor my want a retest or use other means to make the final judgment for his Patient.
We will purchase the basic 29 disease patterns (photos) found in the retina of the eye, at all stages of abnormalities, seen by the hand-held ophthalmoscope and the retinal camera from the many Eye Banks and Universities.
This will become our basic database that we will write our software around, plus our growing data.
The company feels that multiple uses of this instrument will be made;
Like the effectiveness of drugs, vaccines, and diets can be evaluated.
Is the microcirculation improved, made worse or does it remain the same (in various disease states)?
We will generate a computerized report from the retinal examination performed by a Medical Doctor or Physician of a patient using a retinal camera; the report becomes a detailed aid and tool for the Physician to make a medical diagnosis and analysis of each patient, and to save the data as history, so that the Physician can compare and look for changes later.
The detection of abnormalities found in the retina, based on photos taken by the major Eye Banks and Universities in the US.
We will start with one disease pattern at a time and review the others parallel to the project and generate patents for each one.
As we collect photos from our research, this data will be added to our basic database.
Medical Doctors and Physicians have a need for acquiring this data that might be overlooked with conventional methods like using the hand held ophthalmoscope.
(The hand held ophthalmoscope is like a kids hand magnifier and the retinal camera is like a high power electron microscope.)
The FDA, Medicare, and many other insurers approves of the retinal camera.
The instrument is currently manual in that a Medical Doctor examines a patient's retina through a hand held device.
This process has several obvious disadvantages, create false data, many errors, and wrong diagnosis.
First; comparison of a patient's condition over time based on this type of method becomes difficult, and valuable information is often not considered or over looked.
Second; the process becomes very JUDGMENTAL, which implies inconsistency with results.
Third; it is time-consuming and tedious to the Medical Doctor and often difficult to clearly visualize required area.
As a result of this, it is likely that the current practice tends to limit the method's application.
No history is collected for review and analysis. Changes to the patient is lost. After doing about 10 to 25 patients a day, the Medical Doctor can not remember all the conditions of each patient health status and be able to record the patient health status. The Medical only records gross data and not small data that is critical for early detection.
We will contact many Medical Doctors and Physicians at medical conventions around the world. We will set up hospitality suites to invite the doctors to come up and take a picture of their eyes (show and tell).
FDA approval would be a level - I, type of devices and software that are background testing, functioning, tracking, and etc. with other devices or equipment, or processes from the patient.
This level - I - takes 30 days to less then a year for FDA approval.
The risks shall be low for the investor, please see business plan for more details.
Majority of Medical Doctors are willing to use the camera to help them make a better decision for helping the patient.
Plus, the Medical Doctors will use this process for their own family and friends.
The Research and Development Center will be located near Austin, Texas, USA.
Facts to Reduce the Investors Risks:
There is a very strong Medical and Pharmacology needs for Medical Imaging and wanting more Tools.
The FDA and Medicare has approved of the Retinal Camera and the Computer for many years.
Medical Doctors go through many years of schooling before being licensed to practice, but normally only takes an 8 hours or 16 hours of classes of the retina.
The FDA, Medicare, and the Medical Profession have approved the 29 Diseased Patterns seen in the retina of the eye for many years.
The Medical Doctors will make all Diagnosis of each the Patients.
The 29 Diseased Patterns have been approved for over 100 years.
Our process is like a powerful microscope; it magnifies the pictures that have been taken of each patient’s retina and makes the Medical Doctors aware of any diseased patterns found in the patient.
Plus, we can take pictures again and see what has changed in the future.
We would be a FDA level one (I) which takes about 30 days to 0ne year for approval.
Most Medical Doctors are willing to use the camera to help him make a better decision for helping their patient.
Plus, the Medical Doctors will use this process for their family and friends.
The process will help insurance companies to write a clause about the insurer of a disease found.
The marketing of the services, like any other service, is based upon the customers needs.
1. Infectious diseases and aging is ever growing in our world. Need more Medical Doctors.
2. A growing number of lawsuits for the Medical Doctors and lawsuits are why Medical
Doctors want more tools; like this to help them make a better decision.
3. Cities with over 100,000 populations as of today, is 244 cities or 25% of USA
population.
4. The 244 cities have about 75,092,163 of USA populations.
5. Percentage of 1% of doctors is 750.9 (.025%) of the 25% of USA population.
6. The bottom 75% of USA population is 219,921,793, which are cities of less than
100,000 populations.
7. Real market is the whole world, but starting with the US.
There is a very great market in Canada, Western Europe, Asia, Japan, South America, and
other countries that quickly approve a lot of products, equipment, and devices.
But the best judge of the product or device is the Medical Doctors.
The European Union (EU) maintains strict quality-control standards for medical devices,
including extensive reporting requirements, but does so with very little government
involvement. Like our process, which is a low risk product or device, can be marketed
under a self-certification system.
Market Snapshot:
1. Number of Medical Doctors in USA per the 1980 census was about 430,000 Doctors.
(We are being real conservative with the data) (2006)
2. Then remove about - 30,000 specialists, which leave about 400,000 Doctors in USA.
3. To be more conservative, take only one (1%) percent, that equals about 4,000 Doctors.
4. Then, take only one (1) patient in the morning and one (1) in the afternoon or
two (2) per day or ten (10) patients per week.
5. So, 4,000 Doctors times 10 patients per week equals 40,000 patients per week.
6. We will bill the Doctors Fifty ($ 50.00) dollars per patient for our services.
7. Then, $ 50.00 times 40,000 patients per week equals $ 2 Million per week, or
$104 Million per year.
Using a Conservative Number of Doctors
Note: Example; Santa Clara County, California, USA, has 3,600 Doctors. This is only one county.
---------------------------------------------------------------------------------------------------------------------
($130 - $50 our fee = $80) Medical Doctors can make about $80.00 per Patients through the Insurance Companies
and they see about 15 to 25 Patients per day, this is incentive for the doctors to see more patients per day.
(About 15 pat's/day x 5 days = 75 pat's/wk, repeats are about 5 pat's/day x 5 days = 25 pat's/wk.)
The forecasts used in the Company's financial plan are believed to be Very Conservative and the Risks are Very Low, too.
We know that the need is there, for companies like ours to get started before others
jump onto this bandwagon.
At this time there is no competition, and the company plans on aggressively capturing
a dormant market share of this emerging start-up niche.
If a competitor get this idea out there first, that just shows the need is real.
If they get FDA approval, then ours will be easier to do.
If they get Medicare approval, then ours again will be easier to do.
If they get out there first, means that we will not be able to make over trillions of
dollars, maybe we will make only hundreds of billions of dollars.
Just like different car dealers make billions of dollars.
The retinal camera, the computer, the disease patterns, the Medical Doctors, the patients are
not unique, only the software that we write is patentable.
We are not going to use there software and they will not use ours.
Just like IBM software is different from Microsoft software and others software.
They are all patentable in there own way.
I see no real problem.
There will be a full time staff and a temporary staff, plus professional consulting
individuals and services as needed.
University and College students with bright new ideas will help push this idea to
the future.
The company's plans are to hire consultants and temporary personnel and then hire
highly qualified personnel from the temporary group.
Here is a list of some Professional and Technical Consultants (We can find many more
consultants like them.) that are willing to assist this project in the development of
the software.
a. Frederick J.G.M. van Kuijk, M.D., Ph.D., Assistant Professor of Medical
Biochemistry
Stanford University School of Medicine, California
Strong contacts with Lions Eye Bank in San Francisco
Montana Eye Bank Foundation in Missoula, Montana, (Has moved to Huston, Texas)
b. Michael Gaynon, M.D.
Stanford University School of Medicine, California
Department of Ophthalmology
c. Christopher S. Sherman, CRA, RBP, HCA
Director Medical Photography/Illustration
Swedish Medical Center/Seattle, Washington
d. Thomas Gregory Quinn, M.D., Post Doctorate Fellow
Stanford University School of Medicine, California
Center for Research and Disease Prevention
Cardiology at Oakland Cardiovascular Group
e. Christopher Ta, M.D., Assistant Professor
Stanford University School of Medicine, Department of Ophthalmology
Corneal and External Ocular Disease, Refractive Surgery
B.S., University of Minnesota
M.D., University of Minnesota
Residency, Stanford University School of Medicine
Fellowship in Cornea, External Diseases, and Refractive Surgery, University of Texas
f. Doctor Kuldev Singh, M.D., Assistant Professor of Ophthalmology,
Director, Glaucoma Service, Stanford University School of Medicine,
California, has highly recommended Doctor Christopher Ta, M.D.
There are many additional support letters.
Evaluating This Great Company:
Desired Funding Needed : $250M
Net Profit Margin (%)
Yr-1
Yr-2
Yr-3
Yr-4
Yr-5
Yr-6
Yr-7
Yr-8
Yr-9
Yr-10
0.000
0.000
0.373
0.474
0.467
0.498
0.520
0.528
0.538
0.544
$250M is needed to develop the software and market the services, before our competitors
catch on to the idea.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
115,024,861)
(121,834,354)
(12,602,232
The Company is seeking Start-up Funding $250+ million of outside equity
capital, to develop software for the prototype and then ramp up for production of the
Lab Services.
First year ~ ($115,024,861), Second year ~ ($121,834,354), and Third year ~ ($12,602,232) = $249,461,446 Total.
The Company may need additional funds due to unknown setbacks for software development,
staffing, equipment, supplies, building space, consultants, FDA & Medicare approvals,
patents, and etc. for the Production phase.
Simple ROI at 5th year is $3,775,832,708 after taxes / $249,461,446 = 15.14 times the
initial investment.
Future Valuation at 5th year is $503,444,361 at Investor's Share of 49.55%.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Funds Needed for a Greater ROI: ($ 250,000,000 Total USD)
Future valuation in 5th year after taxes at 55% = $ 3,775,832,708
Future valuation in 6th year after taxes at 55% = $ 11,876,544,565
Present value in 5th year at 50% after taxes (7.6 Present value factor) = $ 503,444,361
Present value in 6th year at 50% after taxes (11.4 Present value factor) = $ 1,319,616,063
Initial funding of $ 249,461,446 / Present value of $ 503,444,361 = 49.55% Investor % Ownership
Initial funding of $ 249,461,446 / Present value of $ 1,319,616,063 = 18.90% Investor % Ownership
Simple rate of return (ROI) at 5th year is $ 3,775,832,708 after taxes / $ 249,461,446 = 15.14 times the initial investment
Simple rate of return (ROI) at 6th year is $ 11,876,544,565 after taxes / $ 249,461,446 = 47.61 times the initial investment
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Year: Funds Needed Per 6 Months: $250M , If done by stages:
First 6 Months: (74,139,652)
Second 6 Months: (40,885,209)
Third 6 Months: (57,034,497)
Forth 6 Months: (64,799,857)
Fifth 6 Months: (12,602,232)
Grand Total = ($249,461,446)
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Plan A:
Self-Liquidating funding and Guarantor needed is $250,000,000.00
Plan B:
Project Equity Funding (VC or VC's) needed is $250,000,000.00. (See above break down of
every 6 month funding.)
I am willing to negotiate the equity investment percentage. (I would like redeemable
equity shares.)
Plan C:
Project Loan Funding needed is $250,000,000.00.
I need a grace period for three (3) years for interest and principle for the software
development and startup marketing penetration, before revenue starts.
Then, I need 15 years or more for loan.
Plan D:
Project Loan Funding needed is $250,000,000.00.
If no grace period, then I need $250,000,000.00, plus, extra funding to pay the interest
and principle during the three (3) years for development stage.
Then, I need 15 years or more for loan.
10.00% Duane Harvey % Ownership
15.00% Future Investments or Loans
10.00% Employees Incentives
65.00% Investor % Ownership
100.00% Total %
Example Only:
There is no collateral, guarantees, securities, or guarantors.
I have spent over ten thousand dollars and tens of thousands hours of time when I was
working, on the project to develop the business plan, concepts, and/or etc.
I have talked to over 50 Hospitals and hundreds of Medical Professionals and Doctors
across the USA and the needs are great.
I am not working at the moment and I am getting Social Security Disability Insurance, now.
I have the complete files for $250M available upon request (PDF).
Business Plan $250M:
Pro Forma Plan - 10 Years:
Executive Summary: (Long)
Executive Summary: (Short)
Duane Harvey - Resume:
Medical Professional Consultant's Data:
Marketing Field of Doctors per Population USA:
Professional Engineering & Development - Project Experiences:
WWRI - Company's Resolution:
ESL/TRW - Saved Millions on Designs Issues for Black Hawk Helicopter and Others:
History of Past Professional Business Cards:
World Health Organization - Physicians & Doctors by Countries:
More Imaging Tools are Needed in Pharmaceuticals:
Recession Proof Fields:
For Investor's - Facts to Reduce Risk Concerns:
Investment Incentive Table:
Eye Banks and Universities:
and Extend A Better Quality of Life,
Plus Reduce Misery by Early Detection
or Can Help Make Improvements to Life."
duahar@swbell.net
Duane Harvey - 512-260-0001 near North-West of Austin, Texas, USA
Thanks For Visiting the Company's Web Site!
Last Updated October 11, 2015
No part of this website may be copied and/or reproduced
without expressed or written permission.